IXICO PLC
LSE:IXI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
IXICO PLC
LSE:IXI
|
UK |
|
CAP XX Ltd
LSE:CPX
|
AU |
|
W
|
Wonderfi Technologies Inc
OTC:WONDF
|
CA |
|
C
|
Corazon Mining Ltd
OTC:CRZNF
|
AU |
|
Astria Therapeutics Inc
NASDAQ:ATXS
|
US |
|
Hudson Investment Group Ltd
ASX:HGL
|
AU |
|
A
|
AYER Holdings Bhd
KLSE:SCIPACK
|
MY |
|
I
|
IcapitalBiz Bhd
KLSE:ICAP
|
MY |
|
Vail Resorts Inc
NYSE:MTN
|
US |
|
Jiangsu Eazytec Co Ltd
SSE:688258
|
CN |
|
GMO Media Inc
TSE:6180
|
JP |
|
T
|
Tessellis SpA
MIL:TSL
|
IT |
|
InBioGen Co Ltd
KRX:101140
|
KR |
IXICO PLC
IXICO Plc engages in the provision of technology-enabled specialty services to the global biopharmaceutical industry. The Company’s data analytics services are used by the global biopharmaceutical industry to interpret data from brain scans and digital biosensors to enable trial design, site qualification, patient selection and clinical outcomes. The company provides technology-enabled services across all phases of clinical evaluation. The Company’s services include the collection, analysis, management and reporting of data generated during a clinical study and the outputs from the data analysis. The Company’s integrated digital platform provides a scalable and secure infrastructure for the capture and analysis of regulatory compliant clinical data to enable clients to make better-informed decisions. Its geographical area includes Switzerland, United Kingdom, United States of America, Netherlands, Ireland and Europe.
IXICO Plc engages in the provision of technology-enabled specialty services to the global biopharmaceutical industry. The Company’s data analytics services are used by the global biopharmaceutical industry to interpret data from brain scans and digital biosensors to enable trial design, site qualification, patient selection and clinical outcomes. The company provides technology-enabled services across all phases of clinical evaluation. The Company’s services include the collection, analysis, management and reporting of data generated during a clinical study and the outputs from the data analysis. The Company’s integrated digital platform provides a scalable and secure infrastructure for the capture and analysis of regulatory compliant clinical data to enable clients to make better-informed decisions. Its geographical area includes Switzerland, United Kingdom, United States of America, Netherlands, Ireland and Europe.
